SetPoint’s US pilot study in rheumatoid arthritis shows positive results

Image: The study showed that the bioelectronic medicine was well tolerated with no device-related adverse events through 12 weeks. Photo: Courtesy of SetPoint Medical.



Related Article
Recommended Whitepaper

View More